NASDAQ:ATNF - US68236V3024 - Common Stock
The current stock price of ATNF is 7.04 USD. In the past month the price increased by 274.47%. In the past year, price increased by 291.11%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.89 | 372.04B | ||
AMGN | AMGEN INC | 13.47 | 158.13B | ||
GILD | GILEAD SCIENCES INC | 14.83 | 142.41B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 23.32 | 101.30B | ||
REGN | REGENERON PHARMACEUTICALS | 12.92 | 62.48B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.56B | ||
ARGX | ARGENX SE - ADR | 71.2 | 40.39B | ||
ONC | BEONE MEDICINES LTD-ADR | 6.35 | 37.29B | ||
INSM | INSMED INC | N/A | 27.88B | ||
BNTX | BIONTECH SE-ADR | N/A | 26.66B | ||
NTRA | NATERA INC | N/A | 22.73B | ||
BIIB | BIOGEN INC | 8.7 | 20.42B |
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
180 LIFE SCIENCES CORP
3000 El Camino Real, Bldg 4, Ste 200
Palo Alto CALIFORNIA 10019 US
CEO: James N. Woody
Employees: 4
Phone: 16505070669
The current stock price of ATNF is 7.04 USD. The price decreased by -7.49% in the last trading session.
The exchange symbol of 180 LIFE SCIENCES CORP is ATNF and it is listed on the Nasdaq exchange.
ATNF stock is listed on the Nasdaq exchange.
180 LIFE SCIENCES CORP (ATNF) has a market capitalization of 42.52M USD. This makes ATNF a Nano Cap stock.
180 LIFE SCIENCES CORP (ATNF) currently has 4 employees.
The Revenue of 180 LIFE SCIENCES CORP (ATNF) is expected to grow by 54.15% in the next year. Check the estimates tab for more information on the ATNF EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ATNF does not pay a dividend.
180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.
180 LIFE SCIENCES CORP (ATNF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.78).
The outstanding short interest for 180 LIFE SCIENCES CORP (ATNF) is 47.41% of its float. Check the ownership tab for more information on the ATNF short interest.
ChartMill assigns a technical rating of 9 / 10 to ATNF. When comparing the yearly performance of all stocks, ATNF is one of the better performing stocks in the market, outperforming 99.56% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to ATNF. ATNF may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -12.78. The EPS increased by 54.65% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -160.7% | ||
ROE | -319.99% | ||
Debt/Equity | 0.12 |